舒血宁联用尼莫地平治疗椎基底动脉供血不足性眩晕

评价舒血宁注射液(银杏叶提取物)联用尼莫地平对椎基底动脉供血不足(VBI)性眩晕的临床疗效。方法:对60例VBI性眩晕采用舒血宁注射液加尼莫地平治疗。14天后观察患者临床症状、血液动力学改善情况及经颅多普勒(TCD)血流动力学改变。结果:①两药联用总有效率91.7%;②治疗后血液动力学指标,血流动力学指标均有显著改善。结论:舒血宁联用尼莫地平治疗VBI性眩晕疗效明显。

Objective：To evaluate the efficacy of Ginkgo Biloba Extact combined Ninodipine in the treatment of vertebrobasilar insufficiency. Methods： 60 VBI patients were treated with Ginkgo Biloba Extract and Ninodipine 14 days after the treatment clinical symptoms hemorheology and transoeranial Doppler （TCD）on the patients were observed. Results ： The efficacy rate was91.7%. After treatment the hemorheology index was improved greatly and all of the transocranial （TCD） were significantly higher than that before treatment. Conclusion： Ginkgo Biloba Extract combined with Ninodipine on vertigo patients of vertebrobasilar insufficiency shows obvious curing effectiveness